|1.||Kumar, Anil: 5 articles (05/2014 - 07/2010)|
|2.||Li, Jun: 4 articles (07/2015 - 02/2008)|
|3.||Uehara, Mariko: 4 articles (02/2014 - 06/2003)|
|4.||Kumazawa, Yoshio: 4 articles (01/2011 - 05/2004)|
|5.||Kawaguchi, Kiichiro: 4 articles (01/2011 - 05/2004)|
|6.||Manivasagam, Thamilarasan: 3 articles (09/2015 - 01/2013)|
|7.||Boeira, Silvana P: 3 articles (11/2014 - 01/2013)|
|8.||Jesse, Cristiano R: 3 articles (11/2014 - 01/2013)|
|9.||Goes, André T R: 3 articles (11/2014 - 01/2013)|
|10.||Mishra, Jitendriya: 3 articles (05/2014 - 10/2013)|
04/01/2013 - "This study proves the chemopreventive efficacy of hesperidin against the deleterious traits of colon carcinogenesis including accelerated proliferation, inflammation and persistent oxidative stress."
02/03/2015 - "The study confirms the anti-inflammatory, analgesic and antipyretic activity of EJS which may be attributed to the presence of various phytoconstituents quantified especially hesperidin which have already been reported for its significant role in the treatment of inflammation and associated problems."
01/01/2015 - "Our in vivo study using the permanent left anterior descending coronary artery (LAD) occlusion model demonstrate that one week pre-treatment with yuzu or its major metabolite hesperidin before LAD occlusion significantly attenuated cardiac dysfunction, myocyte apoptosis and inflammation. "
09/01/2014 - "The study suggests that hesperidin exerts its protective effect against CYP-induced hepatotoxicity through upregulation of hepatic PPARγ expression and abrogation of inflammation and oxidative stress. "
05/01/2011 - "In conclusion, this study suggests that hesperidin may enhance immunocompetence, have beneficial effects on nutritional status, and decrease irradiation-induced inflammation in mice."
10/01/2014 - "This work was performed to investigate the possible protective role of hesperidin in ameliorating the effect of experimentally induced intestinal ischemia/reperfusion injury (I/R) on lung tissue, histologically, immunohistochemically and biochemically. "
07/01/2010 - "Hesperidin pre-treatment attenuates NO-mediated cerebral ischemic reperfusion injury and memory dysfunction."
09/01/2009 - "Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin."
11/01/2004 - "Diosmin Hesperidin seems to be effective in the prevention of intestinal reperfusion injury."
08/01/2011 - "The results highlight the involvement of nitric oxide mechanism in the protective effect of hesperidin against ischemia reperfusion injury induced alterations."
03/01/2011 - "Antioxidant capacity of hesperidin from citrus peel using electron spin resonance and cytotoxic activity against human carcinoma cell lines."
10/01/1953 - "Hesperidin-C in the control of edema related to carcinoma."
01/15/1997 - "Feeding of both compounds singly or in combination during the initiation phase caused a significant reduction in the frequency of tongue carcinoma [diosmin, 68% reduction (P < 0.01); hesperidin, 75% reduction (P < 0.005); and the combination regimen, 69% (P < 0.05)]. "
12/01/2015 - "Effect of hesperidin on mice bearing Ehrlich solid carcinoma maintained on doxorubicin."
01/01/2014 - "It was observed that hesperidin induced cell death is nonautophagic and also activate mitogen activated protein kinase ERK1/2. Taken together, the data indicate that hesperidin induces paraptosis like cell death in HepG2 cells with the activation of ERK1/2. Thus our finding suggests that hesperidin inducing paraptosis may offer an alternative tool in human liver carcinoma therapy. "
07/01/2014 - "Rats treated with hesperidin (50 and 100 mg/kg, p.o., 4 weeks) significantly reduced (p < 0.05) hyperglycemia and its metabolic abnormalities induced by intraperitoneal administration of STZ. "
11/01/2012 - "The present study was hypothesized to investigate the beneficial effects of hesperidin and naringin on hyperglycemia-induced oxidative damage in HFD/STZ-induced diabetic rats. "
11/01/2012 - "Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats."
10/01/2004 - "The current results suggest that hesperidin and naringin both play important roles in preventing the progression of hyperglycemia, partly by increasing hepatic glycolysis and glycogen concentration and/or by lowering hepatic gluconeogenesis."
01/01/2015 - "This study demonstrated that a bioflavonoid mixture of curcumin, hesperidin and rutin (CHR) ameliorates hepatic oxidative stress caused by STZ-induced hyperglycemia, resulting in improved hepatic function and glucose regulation."
06/10/2008 - "Thus, oral administration of hesperidin was found to offer protection against gamma-irradiation induced hepatocellular damage and oxidative stress in rats, probably by exerting a protective effect against hepatocellular necrosis via its free radical scavenging and membrane stabilizing ability."
01/01/2014 - "This study demonstrates that hesperidin prevents experimental necrosis and fibrosis. "
03/15/2013 - "Hesperidin treatment significantly attenuated the cisplatin-induced oxidative stress/lipid peroxidation, inflammation (infiltration of leukocytes and pro-inflammatory cytokine), apoptosis/necrosis (caspase-3 activity with DNA damage) as well as increased expression of nitric oxide in the kidney and improved renal function. "
09/01/2010 - "The inhibitory effect of chrysin, kaempferol, morin, silibinin, quercetin, diosmin and hesperidin upon nitric oxide (NO), prostaglandin E(2) (PGE(2)) and tumour necrosis factor-alpha (TNF-alpha) secretion from the LPS-induced RAW 264.7 monocytic macrophage was assessed and IC(50) values obtained. "
|7.||Nitric Oxide (Nitrogen Monoxide)
|9.||Ascorbic Acid (Vitamin C)
|2.||Contraception (Birth Control)